Reply to Glycemic Index/Load Effect on ALS Progression: Potential Interaction with Riluzole
Ann Neurol
.
2024 May 17.
doi: 10.1002/ana.26971.
Online ahead of print.
Authors
Ikjae Lee
1
,
Hiroshi Mitsumoto
1
,
Seonjoo Lee
2
3
,
Edward Kasarskis
4
,
Michael Rosenbaum
5
,
Pam Factor-Litvak
6
,
Jeri W Nieves
6
Affiliations
1
Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
2
Department of Biostatistics and Psychiatry, Columbia University, New York, New York, USA.
3
Mental Health Data Science, New York State Psychiatric Institute, New York, New York, USA.
4
Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.
5
Department of Pediatrics and Medicine, Columbia University Irving Medical Center, New York, New York, USA.
6
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
PMID:
38757649
DOI:
10.1002/ana.26971
No abstract available
Publication types
Letter
Grants and funding
K23NS131586/NS/NINDS NIH HHS/United States